Literature DB >> 12898419

The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption.

Guo-Yu Pan1, Zhi-Jiang Huang, Guang-Ji Wang, J Paul Fawcett, Xiao-Dong Liu, Xiao-Chen Zhao, Jian-Guo Sun, Yuan-Yuan Xie.   

Abstract

The mechanism of action of berberine as an antihyperglycaemic agent was investigated in the Caco-2 cell line. Berberine was found to effectively inhibit the activity of disaccharidases in Caco-2 cells. It also decreased sucrase activity after preincubation with Caco-2 cells for 72 hours. However gluconeogenesis and glucose consumption of Caco-2 cells were not influenced. 2-Deoxyglucose transporting through Caco-2 cell monolayers was decreased by berberine but the effect was not statistically significant. These results suggest that the antihyperglycaemic activity of berberine is at least partly due to its ability to inhibit alpha-glucosidase and decrease glucose transport through the intestinal epithelium.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12898419     DOI: 10.1055/s-2003-41121

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  25 in total

1.  Recent Progress for the Utilization of Curcuma longa, Piper nigrum and Phoenix dactylifera Seeds against Type 2 Diabetes.

Authors:  T Khaliq; M Sarfraz; M A Ashraf
Journal:  West Indian Med J       Date:  2016-04-29       Impact factor: 0.171

2.  Hypoglycemic and hypocholesterolemic effects of Coptis chinensis franch inflorescence.

Authors:  Lujiang Yuan; Dawei Tu; Xiaoli Ye; Jianping Wu
Journal:  Plant Foods Hum Nutr       Date:  2006-09       Impact factor: 3.921

3.  Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study.

Authors:  Xiaochun Wu; Qing Li; Huawen Xin; Airong Yu; Mingyuan Zhong
Journal:  Eur J Clin Pharmacol       Date:  2005-08-26       Impact factor: 2.953

Review 4.  Antidiabetic Potential of Medicinal Plants and Their Active Components.

Authors:  Bahare Salehi; Athar Ata; Nanjangud V Anil Kumar; Farukh Sharopov; Karina Ramírez-Alarcón; Ana Ruiz-Ortega; Seyed Abdulmajid Ayatollahi; Patrick Valere Tsouh Fokou; Farzad Kobarfard; Zainul Amiruddin Zakaria; Marcello Iriti; Yasaman Taheri; Miquel Martorell; Antoni Sureda; William N Setzer; Alessandra Durazzo; Massimo Lucarini; Antonello Santini; Raffaele Capasso; Elise Adrian Ostrander; Muhammad Iqbal Choudhary; William C Cho; Javad Sharifi-Rad
Journal:  Biomolecules       Date:  2019-09-30

5.  Intestinal absorption of berberine and 8-hydroxy dihydroberberine and their effects on sugar absorption in rat small intestine.

Authors:  Shi-Chao Wei; Su Dong; Li-Jun Xu; Chen-Yu Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-04-08

6.  A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome.

Authors:  Flora Affuso; Valentina Mercurio; Antonio Ruvolo; Concetta Pirozzi; Filomena Micillo; Guido Carlomagno; Fabrizia Grieco; Serafino Fazio
Journal:  World J Cardiol       Date:  2012-03-26

7.  Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study.

Authors:  Li Liu; Yun-Li Yu; Jian-Song Yang; Yang Li; Yao-Wu Liu; Yan Liang; Xiao-Dong Liu; Lin Xie; Guang-Ji Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-13       Impact factor: 3.000

8.  Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery.

Authors:  Sunil Kumar Battu; Michael A Repka; Sindhuri Maddineni; Amar G Chittiboyina; Mitchell A Avery; Soumyajit Majumdar
Journal:  AAPS PharmSciTech       Date:  2010-09-15       Impact factor: 3.246

Review 9.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

10.  Efficacy of berberine in patients with type 2 diabetes mellitus.

Authors:  Jun Yin; Huili Xing; Jianping Ye
Journal:  Metabolism       Date:  2008-05       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.